Best Oral Antibiotics for Impetigo
Cephalexin is the first-line oral antibiotic for impetigo at 25-50 mg/kg/day divided into 4 doses (or 250-500 mg four times daily in adults) for 7 days, with clindamycin or trimethoprim-sulfamethoxazole reserved for suspected MRSA or penicillin allergy. 1
First-Line Oral Therapy for Presumed MSSA
The Infectious Diseases Society of America and American Academy of Pediatrics establish a clear hierarchy for oral antibiotics:
- Cephalexin is the preferred first-line agent at 25-50 mg/kg/day divided into 4 doses for children, or 250-500 mg four times daily for adults, for 7 days 1
- Dicloxacillin is an equally effective alternative at the same dosing (25-50 mg/kg/day divided into 4 doses for children, or 250 mg four times daily for adults) for 7 days 1, 2
- Both agents provide excellent coverage for methicillin-susceptible S. aureus, which is now the predominant causative organism 1
The evidence supporting cephalexin is particularly strong, with studies demonstrating that twice-daily dosing may enhance compliance while maintaining equal efficacy to dicloxacillin's four-times-daily regimen 3
When to Switch to MRSA-Covering Agents
In areas with high MRSA prevalence or when MRSA is suspected, empiric therapy must be adjusted:
- Clindamycin at 20-30 mg/kg/day divided into 3 doses for children (or 300-450 mg three to four times daily for adults) for 7 days 1, 2
- Trimethoprim-sulfamethoxazole (TMP-SMX) at 8-12 mg/kg/day (based on trimethoprim component) divided into 2 doses for children (or 1-2 double-strength tablets twice daily for adults) for 7 days 1, 2
- Doxycycline at 2-4 mg/kg/day divided into 2 doses for 7 days, but only in children over 8 years old due to permanent dental staining risk 1
Penicillin Allergy Considerations
For patients reporting penicillin allergy, the approach depends on reaction type:
- Cephalexin remains safe except in patients with type 1 hypersensitivity reactions (anaphylaxis/hives) to β-lactams 1
- Clindamycin is the preferred alternative for true penicillin-allergic patients at 300-450 mg three to four times daily for adults, or 20-30 mg/kg/day in 3 divided doses for children 1, 2
- Macrolides (erythromycin) can be used but resistance rates are rising, making them less reliable 1
Co-Amoxiclav (Amoxicillin-Clavulanate) as an Alternative
The WHO and IDSA list co-amoxiclav as an acceptable oral option:
- Co-amoxiclav provides dual coverage for both S. aureus and S. pyogenes 1
- It is appropriate for extensive disease, outbreaks requiring decreased transmission, or when topical therapy has failed 1
- Standard 7-day duration applies 1
Critical Pitfalls to Avoid
- Never use penicillin or amoxicillin alone—the IDSA explicitly states these lack adequate coverage against S. aureus, which is now the predominant pathogen 1, 4
- Always treat for 7 days with oral antibiotics, not the shorter 5-day course used for topical agents 1, 2
- Avoid tetracyclines in children under 8 years due to permanent dental staining risk 1, 2
- Do not use topical disinfectants as primary therapy—there is little evidence they improve outcomes 1
When Oral Antibiotics Are Indicated Over Topical Therapy
Oral antibiotics should be used instead of topical mupirocin when:
- Numerous lesions are present (extensive disease) 1
- Lesions involve the face, eyelid, or mouth 2
- No improvement after 3-5 days of topical therapy 1, 2
- During outbreaks to decrease transmission 1, 2
- Systemic symptoms are present 2
- Patient is immunocompromised or has diabetes 1
Special Population Considerations
- Pregnant patients: Cephalexin is considered a safe alternative 1
- Immunocompromised patients: Lower threshold for oral antibiotics, monitor closely for treatment failure, and consider longer treatment duration based on clinical response 2
- During outbreaks of poststreptococcal glomerulonephritis: Systemic antimicrobials should be used to eliminate nephritogenic strains 1, 2
Treatment Algorithm Summary
- Limited disease → Topical mupirocin 2% ointment twice daily for 5 days 1
- Extensive disease or oral therapy needed → Cephalexin or dicloxacillin for 7 days 1
- MRSA suspected or high prevalence area → Clindamycin or TMP-SMX for 7 days 1
- Penicillin allergy (non-anaphylactic) → Cephalexin for 7 days 1
- Penicillin allergy (anaphylactic) → Clindamycin for 7 days 1
- No improvement by 3-5 days → Reassess for MRSA, obtain cultures, switch to MRSA-covering agent 2